Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Nuclear Medicine

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 16741304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

  2005cited by this paper
• FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers

  2003cited by this paper
• CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver

  2003cited by this paper
• 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.

  2003cited by this paper
• A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.

  2003cited by this paper
• Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.

  2002cited by this paper
• Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: A study using adenovirus‐mediated antisense targeting

  2001cited by this paper
• Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy.

  2000cited by this paper
• Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results.

  1999influential reference
• A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans.

  1999influential reference
• Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.

  1998influential reference
• Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging.

  1998cited by this paper
• The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism.

  1997cited by this paper
• Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation.

  1996cited by this paper
• Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.

  1996cited by this paper
• Splenic hematopoiesis after granulocyte‐colony stimulating factor therapy in a lupus patient

  1996cited by this paper
• Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines.

  1995cited by this paper
• Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.

  1994cited by this paper
• Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

  1993cited by this paper
• Splenic Extramedullary Hematopoiesis in a Patient Receiving Intermittently Administered Granulocyte ColonyStimulating Factor

  1993cited by this paper
• Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

  1992cited by this paper
• [Hematopoietic growth factors. Biology and clinical applications].

  1992cited by this paper
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor

  1992cited by this paper
• Granulocyte colony-stimulating factor (G-CSF): preclinical and clinical studies.

  1992cited by this paper
• Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

  1992cited by this paper
• Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

  1991cited by this paper
• Hematopoietic growth factors. Biology and clinical applications.

  1989cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper

• Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer

  2021cites this paper
• An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases

  2021cites this paper
• Preparation and Logistic Considerations in Performing PET and PET/Computed Tomography in Pediatric Patients.

  2020cites this paper
• 18F-FDG PET/CT Findings in a Patient With Neutrophilic Leukemoid Reaction Associated With Multiple Myeloma.

  2020cites this paper
• Therapy-Related Imaging Findings in Patients with Sarcoma

  2020cites this paper
• Eflapegrastim Enhanced Efficacy Compared to Pegfilgrastim in Neutropenic Rats Supports Potential for Same-Day Dosing.

  2020cites this paper
• PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?

  2019cites this paper
• Comprehensive analysis of the influence of G-CSF on the biodistribution of 18F-FDG in lymphoma patients: insights for PET/CT scheduling

  2019influential citation
• Skeletal Superscan on 18F-FDG PET/CT in a Patient With Multiple Myeloma.

  2019cites this paper
• Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic Index

  2019cites this paper
• Congenital Penile Rhabdomyosarcoma on FDG PET/CT.

  2018cites this paper
• False-Positive 18F-FDG PET/CT Due to Filgrastim That Induced Extramedullary Liver Hematopoiesis in a Burkitt Lymphoma.

  2018cites this paper
• Interobserver Agreement of Interim and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials

  2018cites this paper
• Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.

  2018cites this paper
• FDG PET imaging in multiple myeloma: implications for response assessments in clinical trials.

  2018cites this paper
• Diagnostic applications of nuclear medicine: Lymphomas

  2017cites this paper
• Polyarteritis nodosa. Diagnostic challenges in a patient with cutaneous vasculitis, psoriasis, psoriatic arthritis and pancytopenia: fatal progression after treatment with G-CSF

  2016cites this paper
• Systemic Immune Response to Vaccination on FDG-PET/CT

  2016cites this paper
• Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance

  2015cites this paper
• FDG-PET(CT)-adapted trials in non-Hodgkin lymphoma

  2015cites this paper
• Optimizing the interval between G-CSF therapy and F-18 FDG PET imaging in children and young adults receiving chemotherapy for sarcoma

  2015cites this paper
• TBCRC 008: Early Change in 18F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer

  2015influential citation
• Evaluation of physiological FDG uptake in the skeleton in adults: is it uniformly distributed?

  2014cites this paper
• Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report

  2014cites this paper
• Pharynx and esophagus: PET/CT

  2013cites this paper
• [Positron emission tomography-computed tomography in tumors of the locomotor apparatus].

  2012cites this paper
• Effet du traitement par pegfilgrastim sur la fixation de la fluorocholine (18F) par la moelle osseuse

  2012cites this paper
• Usefulness of bone window in oncologic patients examined with MDCT and PET-CT.

  2012cites this paper
• The distribution of FDG at PET examinations constitutes a relative mechanism: significant effects at activity quantification in patients with a high muscular uptake

  2012cites this paper
• La tomografía por emisión de positrones asociada con la tomografía computarizada en tumores del aparato locomotor

  2012cites this paper
• Altered FDG uptake patterns in pediatric lymphoblastic lymphoma patients receiving induction chemotherapy that includes very high dose corticosteroids

  2012cites this paper
• C11-Acetate and F-18 FDG PET for Men With Prostate Cancer Bone Metastases: Relative Findings and Response to Therapy

  2011cites this paper
• Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.

  2010cites this paper
• Imaging pharmacodynamics in oncology: the potential significance of “flares”

  2010cites this paper
• Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect.

  2010cites this paper
• 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma

  2010cites this paper
• Pitfalls of interim positron emission tomography scanning in diffuse large B-cell lymphoma.

  2010cites this paper
• Efectividad Diagnóstica de la PET-FDG en el Cáncer de Mama. Revisión Sistemática y Meta-Análsis

  2009cites this paper
• Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas – the PETAL trial

  2009cites this paper
• 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma

  2009cites this paper
• Continuing Education for Nuclear Pharmacists and Nuclear Medicine Professionals

  2009cites this paper
• Clinical significance of diffusely increased splenic uptake on FDG-PET

  2009cites this paper
• Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies

  2008cites this paper
• Patient Preparation and Performance of PET/CT Scans in Pediatric Patients.

  2008cites this paper
• Role of FDG PET in the management of childhood lymphomas--case proven or is the jury still out?

  2008cites this paper
• FDG-PET Evaluation of Response to Treatment.

  2008cites this paper
• Development of a database of realistic simulated whole body [18F]FDG PET images for lymphoma

  2008cites this paper
• Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient.

  2007cites this paper
• Scalene muscle uptake: a potential pitfall in head and neck PET/CT

  2007cites this paper
• Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF

  2007influential citation
• Common Pitfalls in Oncologic FDG PET / CT Imaging

  year unknowncites this paper
• NUCLEAR MEDICINE

  year unknowncites this paper